“渐冻症必然被攻克！”蔡磊发布公开信

Core Viewpoint - The article emphasizes the optimism surrounding the potential breakthroughs in the treatment of Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease, highlighting the advancements made by researchers and the hope of patients for a cure in the near future [1][2]. Group 1: Patient Experiences and Advancements - ALS patient Cai Lei has utilized eye-control technology to communicate, expressing hope for fellow patients and sharing videos of others whose health has improved [1][2]. - Cai Lei's team has collaborated with over 60 top research teams and more than 50 biotech companies, leading to nearly 100 research projects and breakthroughs in 15 drug pipelines and treatment technologies [2][3]. - The "Jianyu Mutual Aid Home" platform has registered over 18,000 ALS patients, creating a statistically significant patient cohort for research [2]. Group 2: Research and Technological Innovations - The team has leveraged artificial intelligence to identify potential pathways for curing ALS, including methods like bone marrow transplantation for immune reconstruction [3]. - The efficiency of research has significantly increased due to advancements in information processing capabilities, allowing for rapid progress in scientific work [3]. Group 3: Historical Context and Future Outlook - Historically, ALS has had a cure rate of zero over the past 200 years, with most patients having a life expectancy of 2 to 5 years post-diagnosis [4]. - Cai Lei's journey from a corporate executive to a patient advocate illustrates the personal stakes involved in ALS research, as he continues to fight for a breakthrough [5]. - The year 2026 is anticipated to be pivotal for the team, with expectations for significant advancements in ALS treatment, reinforcing the belief that a cure is achievable [5][6].